Definitive Biotechnologies LLC
Low-cost disposable medical devices based on licensed University of Pennsylvania technology
- Sector
- Medtech
- Headquarters
- Elkridge, MD
- Founded
- 2021
- Latest Form D
- $900K, Mar 2024
- Total capital
- $3M
- Federal grants
- $750K
- 1 award · 2021
- Rank in peer group#70 of 445
- Private capital raised
- $2.3M
- 2 Form D · last Mar 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 14 pending · first 2025
- Rank in peer group#109 of 445
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$900K
- Private capital raisedForm D · SEC · 1st filing$1.4M
- Federal grantDefense · Phase II · Disposable, multiplex molecular device for simultaneous Point-of-Care COVID-19 / influenza Diagnosis (CIDx)$750K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
1month
from Definitive Biotechnologies LLC’s first federal award to its first private round.
- First federal award · Mar 2021
- Defense · $750K
- First Form D · Apr 2021
- $1.4M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grants#70 · top 16%
- Granted patents#109 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Peter LathamExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 15- PendingLyophilized Or Lyophilizable Indicator Master Mix For Nucleic Acid Amplification And Visual Detection Of A Biological TargetUSPTOApplication 19313270
- GrantedDevice And Method For Detecting Nucleic Acids In Biological SamplesUSPTOUS 12,390,808
- PendingRapid, Microfluidic Diagnostic Device And Method For Biological Sex DeterminationUSPTOApplication 18493412
Show all 15 patent records
- Lyophilized Or Lyophilizable Indicator Master Mix For Nucleic Acid Amplification And Visual Detection Of A Biological TargetMar 5, 2026 · Application 19313270Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesAug 19, 2025 · US 12,390,808Granted
- Rapid, Microfluidic Diagnostic Device And Method For Biological Sex DeterminationApr 25, 2024 · Application 18493412Pending
- Non-toxic Formulation For Collecting Biological Samples, And Device For Capturing And Eluting Nucleic Acids In The SamplesSep 7, 2023 · Application 18176949Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesMar 16, 2023 · Application 17941816Pending
- Overdose Diagnostic And Treatment Device And MethodAug 5, 2021 · Application 17163305Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesApplication PCTUS2022043137Pending
- Rapid, Microfluidic Diagnostic Device And Method For Biological Sex DeterminationApplication PCTUS2023035814Pending
- Lyophilized Or Lyophilizable Indicator Master Mix For Nucleic Acid Amplification And Visual Detection Of A Biological TargetApplication PCTUS2025043884Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesApplication PCTUS2022012178Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesApplication 63243005Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesApplication 63154217Pending
- Overdose Diagnostic And Treatment Device And MethodApplication PCTUS2021015931Pending
- Non-toxic Formulation For Collecting Biological Samples, And Device For Capturing And Eluting Nucleic Acids In The SamplesApplication PCTUS2023014283Pending
- Device And Method For Detecting Nucleic Acids In Biological SamplesApplication 63136435Pending
Related companies, and why
- LXS, LLCSimilar federal contract value in Medtech · null in contracts
- PRE-CANCER DIAGNOSIS, LLCSimilar federal contract value in Medtech · null in contracts
- Strive Tech Inc.Similar federal contract value in Medtech · null in contracts
- ONTERA INC.Similar federal contract value in Medtech · null in contracts
- Diversified 3D Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Trugenomix Health, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .